Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Search Results

Refine Your Search

By Sector

Sort by: Date|Relevance

Who Said Traders and Investor are Emotional Right Now?

Nearing the end of 2019, our research team continues to attempt to dissect the market rally in an effort to present credible research and timely insights to skilled technical traders. We recently authored a research article discussing the potential that the US Stock market is ...
Chris Vermeulen | December 20, 2019 |

Air Liquide, NEL ASA, RHC Royal Helium Corp. - Helium replaces hydrogen

Helium is a chemical element and is lighter than air. It belongs to the pure gases, is colourless, odourless, tasteless and is generally regarded as non-toxic. Because of these characteristics, helium is already replacing hydrogen in industrial use. However, experts warn of a ...
Mario Hose | May 27, 2020 |

Daimler, Lufthansa, Royal Helium - the crisis is an opportunity for wealth

As is well known, the future is traded on the stock exchange and for this reason investors are always looking for the right time to start a new investment. It can be political decisions or new technological trends that cause sales and profits to soar. In the case of Covid-19, ...
Mario Hose | September 8, 2020 |

Feb 28th 2020, Silver Chartbook – The weakest link

The weakest link The weakest link is you . That is not always easy to admit, but it is factual, that the main cause for large draw downs is human error. The list of errors in market participation is long. For example running stops or sitting frozen behind the monitor ...
Korbinian Koller | February 28, 2020 |

Mar 27th 2020, Silver Chartbook – Brace yourself

Brace yourself Right now you might find yourself in this first moment of catching a breath. You might have started getting used to a work from home. In addition, you might be feeling more prepared having stacked up on essentials. Maybe you even got used to this new wo...
Korbinian Koller | March 27, 2020 |

Buzz on the Bullboards: The ups and downs of the fall investing season

For us here on the West Coast it has been a hot autumn and the markets have been just as intense. This means Bullboard activity has also been sizzling. Many sectors have seen new (and returning) companies generate a lot of discussion as a result. This week we&CloseCur...
Jonathon Brown | October 13, 2022 |

Crunching Some Numbers and What They Say – Part I

This is one of those articles that are packed with resources showing your what to expect for various assets both long-term and short-term and will guide you through these volatile times and this year. Our friends and followers continue to contact us asking what to expect a...
Chris Vermeulen | March 16, 2020 |

The Revolutionary Co. That’s Breaking Through the Blood Brain Barrier

(Click image to play video) Delivery of therapeutics across the blood-brain barrier (BBB) and into the brain has been the single greatest challenge to treating hundreds of common and rare neurological diseases, including brain cancers, neurodegenerative diseases...
Dave Jackson | December 1, 2020 |

Apellis Pharma Shares Rise 20% on Positive Top-line Data in Phase 3 PNH Trial

Shares of Apellis Pharmaceuticals opened 35% higher and established a new 52-week intraday high price today after the company announced positive top-line results from its Phase 3 head-to-head study of Pegcetacoplan (APL-2) versus Eculizumab in patients with Paroxysmal Nocturna...
Streetwise Reports | January 8, 2020 |

Gold Cycle Forecast Signals Bottom Is Near

It is absolutely amazing how the precious metals markets have followed our October 2018 predictions almost like clockwork. Our call for an April 21~24 momentum base below $1300 followed by an extensive rally to levels above $1550 has been playing out almost like we scripted th...
Chris Vermeulen | October 16, 2019 |
1 2 3 4 5 6